Guangsheng He

1.1k total citations
117 papers, 701 citations indexed

About

Guangsheng He is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Guangsheng He has authored 117 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Hematology, 38 papers in Immunology and 29 papers in Genetics. Recurrent topics in Guangsheng He's work include Hematopoietic Stem Cell Transplantation (39 papers), Acute Myeloid Leukemia Research (29 papers) and Blood groups and transfusion (23 papers). Guangsheng He is often cited by papers focused on Hematopoietic Stem Cell Transplantation (39 papers), Acute Myeloid Leukemia Research (29 papers) and Blood groups and transfusion (23 papers). Guangsheng He collaborates with scholars based in China, Switzerland and United Kingdom. Guangsheng He's co-authors include Xiaoqing Liu, Run Zhang, Ming Hong, Depei Wu, Shuai Wang, Aining Sun, Zhengzheng Fu, Jianyong Li, Jie Bai and Xiaowen Tang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

In The Last Decade

Guangsheng He

108 papers receiving 685 citations

Peers

Countries citing papers authored by Guangsheng He

Since Specialization

Citations

This map shows the geographic impact of Guangsheng He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangsheng He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangsheng He more than expected).

Fields of papers citing papers by Guangsheng He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangsheng He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangsheng He. The network helps show where Guangsheng He may publish in the future.

Co-authorship network of co-authors of Guangsheng He

This figure shows the co-authorship network connecting the top 25 collaborators of Guangsheng He. A scholar is included among the top collaborators of Guangsheng He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangsheng He. Guangsheng He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase III Randomized COMMODORE 2 Trial: 2-Year Efficacy and Safety of Crovalimab in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Naive to Complement Inhibition 2024 ·Blood ·Alexander Röth, Guangsheng He, Andrés Brodsky, Chatree Chai‐Adisaksopha, (unknown), Anna Gayà, Martin Höglund, Richard Kelly, (unknown), Je‐Hwan Lee, Naoshi Obara, Antonio M. Risitano, (unknown), (unknown), Brittany Gentile, Zilu Zhang, Bing Han, Sasha Sreckovic	0
2	Safety of Crovalimab Versus Eculizumab in Patients With Paroxysmal Nocturnal Haemoglobinuria (PNH): Pooled Results From the Phase 3 COMMODORE Studies 2024 ·European Journal Of Haematology ·Alexander Röth, Rong Fu, Guangsheng He, Hazzaa Alzahrani, Sheng‐Chieh Chou, Yosr Hicheri, Maciej Kaźmierczak, (unknown), Michihiro Uchiyama, (unknown), (unknown), (unknown), (unknown), Nicolò Compagno, (unknown), (unknown), Sasha Sreckovic, Phillip Scheinberg	1
3	Efficacy and safety of avatrombopag in aplastic anemia patients with liver disease 2023 ·Journal of Translational Internal Medicine ·Huaquan Wang, Guangsheng He, Jinsong Jia, Mengyuan Liu, Hui Liu, Ting Wang, Chunyan Liu, Rong Fu	5
4	Transfusion-dependent non-severe aplastic anemia: characteristics and outcomes in the clinic 2023 ·Frontiers in Immunology ·Yawen Zhang, (unknown), Suli Wang, (unknown), Jinsong Jia, (unknown), Guangsheng He, Jianyong Li	1
5	The Efficacy of Hetrombopag Combined with Cyclosporine a in Patients with Transfusion-Dependent Non-Severe Aplastic Anemia 2023 ·Blood ·(unknown), Xiaoyu Chen, Yawen Zhang, Guangsheng He, Jianyong Li	0
6	Prolonged use of eltrombopag in patients with severe aplastic anemia in the real world 2023 ·Clinical and Experimental Medicine ·Ruixin Li, Ningling Wang, Xingxing Chai, (unknown), Kangkang Liu, Hailong He, (unknown), Yang Yan, Jinsong Jia, Donghua Zhang, (unknown), (unknown), Guangsheng He, Jianyong Li	3
7	Efficacy and safety of ruxolitinib in patients with myelofibrosis and low platelet count (50 × 10⁹/L to <100 × 10⁹/L) at baseline: the final analysis of EXPAND 2022 ·Therapeutic Advances in Hematology ·Paola Guglielmelli, Jean‐Jacques Kiladjian, Alessandro M. Vannucchi, Minghui Duan, Haitao Meng, Ling Pan, Guangsheng He, Srđan Verstovšek, Françoise Boyer, Fiorenza Barraco, Dietger Niederwieser, Ester Pungolino, (unknown), Claire Harrison, (unknown), (unknown), (unknown), (unknown), Peter A.W. te Boekhorst, Heinz Gisslinger	9
8	A real-world experience of eltrombopag plus rabbit antithymocyte immunoglobulin–based IST in Chinese patients with severe aplastic anemia 2022 ·Annals of Hematology ·(unknown), Ruixin Li, (unknown), Jinsong Jia, (unknown), Donghua Zhang, Guangsheng He, (unknown)	5
9	Iron chelation of hetrombopag in aplastic anemia: a post hoc analysis of a phase II study 2022 ·Annals of Hematology ·(unknown), Xin Zhao, Guangsheng He, Hong Chang, Bing Han, Sujun Gao, Shunqing Wang, Tong Chen, Fei Li, Yi Wang, Xiaoyan Ge, Rong Fu, (unknown), Yingmei Li, Hong Liu, Xinjian Liu, Miao Miao, Liansheng Zhang, (unknown)	5
10	Frontline Therapy Options for Adults With Newly Diagnosed Severe Aplastic Anemia: Intensive immunosuppressive Therapy Plus Eltrombopag or Matched Sibling Donor Hematopoietic Stem Cell Transplantation? 2022 ·Transplantation and Cellular Therapy ·Lifang Huang, Li Li, Jinsong Jia, Yan Yang, (unknown), Fankai Meng, Donghua Zhang, Guangsheng He	7
11	Immunosuppressive therapy for elderly-acquired pure red cell aplasia: cyclosporine A may be more effective 2020 ·Annals of Hematology ·Xiaoqing Liu, (unknown), Lang Chen, Yan Yang, (unknown), Ruinan Lu, Shuai Wang, Jianfu Zhang, Ming Hong, Yu Zhu, Guangsheng He, Jianyong Li	7
12	ND4 mutations are more prevalent in patients with acute myeloid leukemia of M2 morphology 2018 ·Translational Cancer Research ·Min Xu, Xiaoli Zhao, (unknown), Wenyi Shen, Ming Hong, Guangsheng He, Han Zhu, (unknown), Sixuan Qian, Jianyong Li, Chun Qiao	1
13	EXPAND, a dose-finding study of ruxolitinib in patients with myelofibrosis and low platelet counts: 48-week follow-up analysis 2018 ·Haematologica ·Alessandro M. Vannucchi, Peter A.W. te Boekhorst, Claire Harrison, Guangsheng He, Marianna Caramella, Dietger Niederwieser, (unknown), Minghui Duan, (unknown), (unknown), (unknown), Heinz Gisslinger	32
14	Primary Bone Marrow Lymphoma Initially Presenting with Cytopenia: A Report of Eight Cases 2017 ·Blood ·Ming Hong, Shuai Wang, Han Zhu, Rong Wang, Jianyong Li, Guangsheng He	2
15	Interleukin-2 and Interleukin-8 Gene Polymorphisms and Acquired Aplastic Anemia Risk in a Chinese Population 2017 ·Cellular Physiology and Biochemistry ·Xuejie Zhang, (unknown), Yang Yan, Liucheng Rong, Guangsheng He, Hailong He, Yao Xue, Yongjun Fang, Yaping Wang	2
16	Polymorphisms of the TGF-β1 gene and the risk of acquired aplastic anemia in a Chinese population 2016 ·Annals of Hematology ·(unknown), Liucheng Rong, Guangsheng He, Hailong He, (unknown), Yang Yan, Yao Xue, Yongjun Fang	4
17	Combination of Rapamycin and Imatinib in Treating Refractory Chronic Myeloid Leukemia Myeloid Blast Crisis: a Case Report 2013 ·Chinese Medical Sciences Journal ·Jing Xie, Xiang Zhang, (unknown), Guangsheng He, Yun Zhao, Depei Wu	2
18	Outcomes of CAG Regimen for Refractory Biphenotypic Acute Leukemia Patients 2009 ·Chinese Medical Sciences Journal ·Guangsheng He, Xiang Zhang, Depei Wu, (unknown), Zhengming Jin, Huiying Qiu, Miao Miao, Xiaowen Tang, Zhengzheng Fu, Yue Han	4
19	[Proliferation of bone marrow hematopoietic stem cells and function of T helper lymphocytes of patients with immuno-related pancytopenia]. 2004 ·PubMed ·Rong Fu, Zonghong Shao, Hong Liu, Hong He, Juan Sun, Mingfeng Zhao, Guangsheng He, (unknown), Jie Bai, (unknown), (unknown)	7
20	Physics of nonlinear optics 1999 ·CERN Document Server (European Organization for Nuclear Research) ·Guangsheng He	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact